Science is consistently striving to create better lives for everyone on Earth. Behind every breakthrough, there is much research and technological development involved. At the end of last year, Nature Genetics and Nature Medicine published a collection of 14 milestones in cancer filed in recent decades to showcase major advances in the understanding of cancer and the development of novel therapies that are improving patient survival.

See more here: https://www.nature.com/immersive/d42859-020-00083-8/index.html

Among these milestones, Next Generation Sequencing (NGS) has been mentioned many times regarding its positive influence in cancer research. From entire genome sequencing to single-cell sequencing, NGS technology makes it possible to obtain comprehensive gene data in a short time. Then, comparative studies are conducted to discover the difference between healthy cells and tumor cells.

NGS’s contribution is not limited to cancer research. The development of NGS has been accelerating the development and application of cancer and many other complex disease diagnoses at the genetic level, while also promoting the progress of personalized medicine.

Obtaining credible results in NGS experiments requires the support of high-quality tools, and adapter ligation is a critical step in the NGS process. To be your reliable partner, Synbio Technologies can synthesis any NGS adapters (for example, Illunimar and MGI), as well as your own custom designs. Comprehensive adapter types are available, including single or double-ended indexes, as well as dual index plus unique molecule label. All of the NGS adapters are manufactured in compliance with ISO 9001:2015 & ISO 13485:2016 quality management system standards to ensure the efficiency of adapter ligation and the stability of library construction.